North America Laparoscopic Devices Market Outlook (2021-2031)
Description
The North America laparoscopic devices market is projected to reach approximately USD 12,187.2 million by 2031, up from USD 6,348.7 million in 2024. This growth represents a compound annual growth rate (CAGR) of 9.8% from 2025 to 2031.
Executive Summary and Market Analysis:
The laparoscopic devices market in North America is experiencing substantial growth, driven by the strength of developed healthcare systems, the adoption of advanced surgical technologies, a robust regulatory environment, and significant investment in research and development. North America's dominance in this field is characterized by a quick adoption of minimally invasive surgery (MIS) over traditional open surgery. The shift towards laparoscopic surgery is largely attributed to perceived benefits such as reduced postoperative pain, shorter hospital stays, and quicker recovery times.
In 2024, North America held the largest share of the global laparoscopic devices market, with varying reports indicating that it accounted for a significant portion of worldwide market revenues.
A key factor supporting North America's market leadership is the high prevalence of chronic diseases, including obesity, cardiovascular disorders, and certain cancers, which often necessitate surgical intervention. For instance, a projection by the American College of Cardiology in August 2022 forecasts increases in major cardiovascular risk factors in the United States from 2025 to 2060, including a 39.3% rise in diabetes (to 55 million) and an 18.3% rise in obesity (to 126 million). These chronic diseases lead to a greater demand for laparoscopic procedures and robot-assisted surgeries.
Market Segmentation Analysis:
The laparoscopic devices market is categorized by product, application, and end-user:
By Product:The market includes energy systems, laparoscopes, suction devices, robot-assisted systems, insufflation devices, and access devices. The laparoscope segment led the market in 2024.
By Application:The market is segmented into general surgery, bariatric surgery, gynecological surgery, colorectal surgery, and others. The general surgery segment held the largest market share in 2024.
By End User:The market is divided into hospitals and clinics, and ambulatory surgical centers, with hospitals and clinics accounting for the largest share in 2024.
Market Outlook:
The North American laparoscopic devices market is segmented into the United States, Canada, and Mexico. This region is recognized as a dominant and technologically advanced segment of the global healthcare industry, contributing the highest revenue share to the global laparoscopic devices market in 2024. The market is characterized by continuous technological innovations and frequent product launches, including the rapid growth of robot-assisted surgical systems, which are expanding at an annual rate of approximately 25%. For example, in May 2024, Advanced Laparoscopic Surgeons of Morris partnered with the New York Bariatric Group to improve patient access to advanced surgical techniques, highlighting the commitment to MIS.
Additionally, the increasing use of 4K and 3D imaging systems for enhanced visualization, along with innovations in energy devices and hand instruments, continue to extend the capabilities of laparoscopic procedures. The presence of major global medical device manufacturers and their strategic investments in research and development and distribution networks further reinforce North America's leading position, with many new product approvals and launches occurring in the region. Notable innovations include new disposable suction-irrigation systems with integrated smoke filters introduced in late 2024 and early 2025.
Country Insights:
Based on region, the North America laparoscopic devices market is further divided into the United States, Canada, and Mexico. In 2024, the United States held the largest market share.
The United States is at the forefront of technology and innovative design. This includes the rapid adoption of existing robot-assisted surgery systems, which are currently growing at an annual rate of 25%. More than 2,000 hospitals in the United States are utilizing robotic surgery systems. For example, Intuitive Surgical's da Vinci systems performed over 2.68 million surgical procedures worldwide in 2024. Notably, in February 2024, Virtual Incision Corporation received FDA approval for its miniaturized robotic-assisted surgery device, the MIRA™ Surgical System, specifically for colectomy procedures. Additionally, in November 2023, Ethicon (a subsidiary of Johnson & Johnson) launched an AI-powered laparoscopic surgical simulation platform.
In Mexico, the high obesity rates (over 30% of the population, projected to rise to 39% by 2030) directly lead to increased demand for bariatric surgeries, which is a key application area for laparoscopic devices. Canada also presents a significant and growing opportunity for laparoscopic devices due to its advanced healthcare system, the expanding use of minimally invasive procedures, and the rising prevalence of chronic diseases. For instance, surgical volumes in Canada returned to pre-COVID-19 pandemic levels in 2022-2023, totaling approximately 2.22 million procedures. This volume increased by 5% in 2023-2024, which included a 10% rise in day surgeries, many of which were laparoscopic procedures.
Company Profiles
Key players in the North America laparoscopic devices market include Medtronic Plc, Johnson & Johnson, Olympus Corp, Stryker Corp, Karl Storz SE & Co KG, Boston Scientific Corp, B. Braun SE, Smith & Nephew Plc, Conmed Corp, and Intuitive Surgical Inc. These companies employ strategies such as expansion, product innovation, and mergers and acquisitions to remain competitive and offer innovative products to consumers.
Executive Summary and Market Analysis:
The laparoscopic devices market in North America is experiencing substantial growth, driven by the strength of developed healthcare systems, the adoption of advanced surgical technologies, a robust regulatory environment, and significant investment in research and development. North America's dominance in this field is characterized by a quick adoption of minimally invasive surgery (MIS) over traditional open surgery. The shift towards laparoscopic surgery is largely attributed to perceived benefits such as reduced postoperative pain, shorter hospital stays, and quicker recovery times.
In 2024, North America held the largest share of the global laparoscopic devices market, with varying reports indicating that it accounted for a significant portion of worldwide market revenues.
A key factor supporting North America's market leadership is the high prevalence of chronic diseases, including obesity, cardiovascular disorders, and certain cancers, which often necessitate surgical intervention. For instance, a projection by the American College of Cardiology in August 2022 forecasts increases in major cardiovascular risk factors in the United States from 2025 to 2060, including a 39.3% rise in diabetes (to 55 million) and an 18.3% rise in obesity (to 126 million). These chronic diseases lead to a greater demand for laparoscopic procedures and robot-assisted surgeries.
Market Segmentation Analysis:
The laparoscopic devices market is categorized by product, application, and end-user:
By Product:The market includes energy systems, laparoscopes, suction devices, robot-assisted systems, insufflation devices, and access devices. The laparoscope segment led the market in 2024.
By Application:The market is segmented into general surgery, bariatric surgery, gynecological surgery, colorectal surgery, and others. The general surgery segment held the largest market share in 2024.
By End User:The market is divided into hospitals and clinics, and ambulatory surgical centers, with hospitals and clinics accounting for the largest share in 2024.
Market Outlook:
The North American laparoscopic devices market is segmented into the United States, Canada, and Mexico. This region is recognized as a dominant and technologically advanced segment of the global healthcare industry, contributing the highest revenue share to the global laparoscopic devices market in 2024. The market is characterized by continuous technological innovations and frequent product launches, including the rapid growth of robot-assisted surgical systems, which are expanding at an annual rate of approximately 25%. For example, in May 2024, Advanced Laparoscopic Surgeons of Morris partnered with the New York Bariatric Group to improve patient access to advanced surgical techniques, highlighting the commitment to MIS.
Additionally, the increasing use of 4K and 3D imaging systems for enhanced visualization, along with innovations in energy devices and hand instruments, continue to extend the capabilities of laparoscopic procedures. The presence of major global medical device manufacturers and their strategic investments in research and development and distribution networks further reinforce North America's leading position, with many new product approvals and launches occurring in the region. Notable innovations include new disposable suction-irrigation systems with integrated smoke filters introduced in late 2024 and early 2025.
Country Insights:
Based on region, the North America laparoscopic devices market is further divided into the United States, Canada, and Mexico. In 2024, the United States held the largest market share.
The United States is at the forefront of technology and innovative design. This includes the rapid adoption of existing robot-assisted surgery systems, which are currently growing at an annual rate of 25%. More than 2,000 hospitals in the United States are utilizing robotic surgery systems. For example, Intuitive Surgical's da Vinci systems performed over 2.68 million surgical procedures worldwide in 2024. Notably, in February 2024, Virtual Incision Corporation received FDA approval for its miniaturized robotic-assisted surgery device, the MIRA™ Surgical System, specifically for colectomy procedures. Additionally, in November 2023, Ethicon (a subsidiary of Johnson & Johnson) launched an AI-powered laparoscopic surgical simulation platform.
In Mexico, the high obesity rates (over 30% of the population, projected to rise to 39% by 2030) directly lead to increased demand for bariatric surgeries, which is a key application area for laparoscopic devices. Canada also presents a significant and growing opportunity for laparoscopic devices due to its advanced healthcare system, the expanding use of minimally invasive procedures, and the rising prevalence of chronic diseases. For instance, surgical volumes in Canada returned to pre-COVID-19 pandemic levels in 2022-2023, totaling approximately 2.22 million procedures. This volume increased by 5% in 2023-2024, which included a 10% rise in day surgeries, many of which were laparoscopic procedures.
Company Profiles
Key players in the North America laparoscopic devices market include Medtronic Plc, Johnson & Johnson, Olympus Corp, Stryker Corp, Karl Storz SE & Co KG, Boston Scientific Corp, B. Braun SE, Smith & Nephew Plc, Conmed Corp, and Intuitive Surgical Inc. These companies employ strategies such as expansion, product innovation, and mergers and acquisitions to remain competitive and offer innovative products to consumers.
Table of Contents
145 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. Laparoscopic Devices Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. Laparoscopic Devices Market – Key Market Dynamics
- 5.1 Laparoscopic Devices Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints:
- 6. North America Laparoscopic Devices Market Analysis
- 6.1 North America Laparoscopic Devices Market Revenue (US$ Million), 2021–2031
- 6.2 North America Laparoscopic Devices Market Forecast Analysis
- 7. North America Laparoscopic Devices Market Analysis – by Product
- 7.1 Energy Systems
- 7.1.1 Overview
- 7.1.2 Energy Systems: North America Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 7.2 Laparoscopes
- 7.2.1 Overview
- 7.2.2 Laparoscopes: North America Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 7.3 Suction Devices
- 7.3.1 Overview
- 7.3.2 Suction Devices: North America Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 7.4 Robot Assisted Systems
- 7.4.1 Overview
- 7.4.2 Robot Assisted Systems: North America Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 7.5 Insufflation Devices
- 7.5.1 Overview
- 7.5.2 Insufflation Devices: North America Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 7.6 Access Devices
- 7.6.1 Overview
- 7.6.2 Access Devices: North America Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 8. North America Laparoscopic Devices Market Analysis – by Application
- 8.1 General Surgery
- 8.1.1 Overview
- 8.1.2 General Surgery: North America Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 8.2 Bariatric Surgery
- 8.2.1 Overview
- 8.2.2 Bariatric Surgery: North America Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 8.3 Gynecological Surgery
- 8.3.1 Overview
- 8.3.2 Gynecological Surgery: North America Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 8.4 Colorectal Surgery
- 8.4.1 Overview
- 8.4.2 Colorectal Surgery: North America Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: North America Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 9. North America Laparoscopic Devices Market Analysis – by End User
- 9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Clinics: North America Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 9.2 Ambulatory Surgical Centers
- 9.2.1 Overview
- 9.2.2 Ambulatory Surgical Centers: North America Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 10. North America Laparoscopic Devices Market – Country Analysis
- 10.1 North America
- 10.1.1 North America Laparoscopic Devices Market – Revenue and Forecast Analysis – by Country
- 10.1.1.1 North America Laparoscopic Devices Market – Revenue and Forecast Analysis – by Country
- 10.1.1.2 United States: Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 10.1.1.2.1 United States: Laparoscopic Devices Market Share – by Product
- 10.1.1.2.2 United States: Laparoscopic Devices Market Share – by Application
- 10.1.1.3 Canada: Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 10.1.1.3.1 Canada: Laparoscopic Devices Market Share – by Product
- 10.1.1.3.2 Canada: Laparoscopic Devices Market Share – by Application
- 10.1.1.4 Mexico: Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 10.1.1.4.1 Mexico: Laparoscopic Devices Market Share – by Product
- 10.1.1.4.2 Mexico: Laparoscopic Devices Market Share – by Application
- 11. Competitive Landscape
- 11.1 Heat Map Analysis by Key Players
- 11.2 Company Positioning and Concentration
- 12. Industry Landscape
- 12.1 Overview
- 12.2 Market Initiative
- 12.3 Partnerships and Collaborations
- 12.4 Other Developments
- 13. Company Profiles
- 13.1 Medtronic Plc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 Johnson & Johnson
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 Olympus Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 Stryker Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 Karl Storz SE & Co KG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 Boston Scientific Corp
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 B Braun SE
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 Smith & Nephew Plc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 Conmed Corp
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 13.10 Intuitive Surgical Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
- 14. Appendix
- 14.1 About Business Market Insights
- 14.2 List of Abbreviations
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
